Concepedia

Andreas Baumann

AB

15

Publications

460

Citations

12

H-Index

1993

Active since

Affiliations

Bayer (Germany)(Current)

Roche (Switzerland)

Novartis (Switzerland)

UCB Pharma (United Kingdom)

UCB Pharma (Belgium)

Andreas Baumann is an author at Bayer (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1993–2021

15

Publications

15

Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath<sup>®</sup>) in patients with chronic lymphocytic leukaemia and its link to treatment response

Diane R. Mould, Andreas Baumann, Jens Kuhlmann et al. · British Journal of Clinical Pharmacology · 2007 · 113 citations · Full text

The Use of Tissue Slices for Pharmacotoxicology Studies

Peter H. Bach, Alison E.M. Vickers, Robyn L. Fisher et al. · Alternatives to Laboratory Animals · 1996 · 84 citations

, , +3

Mechanistic Modeling of the Pharmacodynamic and Pharmacokinetic Relationship of Tissue Factor Pathway Inhibitor-Neutralizing Antibody (BAY 1093884) in Cynomolgus Monkeys

Jian-Ming Gu, Xiao-Yan Zhao, Thomas Schwarz et al. · The AAPS Journal · 2017 · 41 citations · Full text

, , +19

Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction

Andreas Baumann, Isabel Piel, Frank Hucke et al. · European Journal of Pharmaceutical Sciences · 2019 · 32 citations · Full text

New challenges and opportunities in nonclinical safety testing of biologics

Andreas Baumann, Kelly M. Flagella, Roy Forster et al. · Regulatory Toxicology and Pharmacology · 2014 · 26 citations

, , +10

Rows per page

1–5 of 15